Common Prognostic Scoring Systems for Patients Presenting with Brain Metastases

Author Info

Ahmet Kucuk Berrin Pehlivan Duygu Sezen Erkan Topkan Esma Didem Ikiz Eyub Yasar Aydemir Nulifer Kılıc Durankus Sukran Senyurek Ugur Selek Yasemin Bolukbasi

Corresponding Author

Erkan Topkan
Baskent University Medical Faculty, Department of Radiation Oncology, Adana, Turkey

A B S T R A C T

Brain metastases (BM) of various primaries merely remain the most prevalent type of intracranial tumors, and approximately 25% of all cancer patients are diagnosed with this poor prognostic disease condition somewhere during their treatment course. Contingent upon the general wellbeing status of the potential patient, currently available major treatment options typically include palliative radiotherapy, chemotherapy, and best supportive care. Various published studies have convincingly shown the likelihood to stratify BM patients into particular prognostic gatherings according to the conceivable combinations of multiple patients- and tumor-related characteristics; namely the prognostic scoring systems, which might be useful in the accurate prediction of survival, and thusly, the appropriate choice of the best-fit treatment alternative. In this present article, we meant to review the pros and cons of the as of now accessible and broadly acknowledged prognostic scoring systems for BMs and their clinical values.

Article Info

Article Type

Research Article

Publication history

Received: Thu 20, Feb 2020
Accepted: Mon 09, Mar 2020
Published: Tue 17, Mar 2020

Copyright

© 2023 Erkan Topkan. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.
DOI: 10.31487/j.COR.2020.03.03